Cystic fibrosis receptors during developmental stages
- Number of Honour Places Available
- 1
- Number of Master Places Available
- 1
| Primary Supervisor | Number | Webpage | |
|---|---|---|---|
| Dr Elena Schneider-Futschik | elena.schneider@unimelb.edu.au | Personal web page |
| Co-supervisor | Number | Webpage | |
|---|---|---|---|
| Prof Norman Saunders |
Summary The Cystic Fibrosis Pharmacology group is are interested in the mechanisms of drug action, drug-drug interactions and drug safety of cystic fibrosis drugs during pregnancy and breastfeeding.
Project Details
The cystic fibrosis modulators have transformed clinical outcomes for many CF patients by improving survival and general health. However, the much greater prevalence of CF women reaching childbearing age means increasing numbers of women taking these medications face very difficult decisions when it comes to having a family. This study will aid clinicians in prescribing CFTR modulators to pregnant women on how these drugs will transfer across essential barriers during different developmental stages.Key Contact
For further information about this research, please contact a supervisor.
MDHS Research library
Explore by researcher, school, project or topic.